Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Envoplakin-like protein (EVPLL) is a predicted human protein with sequence similarity to the "envoplakin" protein, a well-characterized cytoskeletal linker protein that serves as a precursor for the cornified envelope of stratified epithelial cells. The function of EVPLL is not well understood. Databases predict its involvement in intermediate filament cytoskeleton organization and note it as a protein-coding gene with limited functional data in the literature. No clear evidence supports a therapeutic, receptor, enzyme, or characterized disease role for this specific protein. EVPLL is closely related by sequence to envoplakin (EVPL), but the precise physiological or pathological function is unvalidated. Key caveats and points of correction: - The name "Envoplakin-like protein" (EVPLL) appears in gene/protein databases, but there is no evidence in the published literature that it is an established therapeutic target, disease gene, or receptor. - EVPLL is not to be confused with "Envoplakin" (EVPL), which is strongly characterized as a plakin family cytoskeletal protein involved in desmosome/cornified envelope assembly, and has disease associations in paraneoplastic pemphigus and esophageal cancer. - Some information in databases lists predicted associations for EVPLL, but no functional/mechanistic, biomarker, drug, or disease role is confirmed in research for this specific gene/protein at present. If you intend to refer to the well-studied envoplakin (EVPL) protein, clarify spelling or update to that protein entry. If you do mean "envoplakin-like" (EVPLL), it is best considered as a hypothetical or database-inferred protein, not a validated target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Envoplakin-like protein (EVPLL).